K
Kodiak Sciences
Designing and developing novel therapies for the treatment of retinal disease
About Kodiak Sciences
Kodiak Sciences Inc. is a biopharmaceutical company focused on researching, developing, and commercializing transformative therapeutics for high prevalence retinal diseases. The company primarily serves patients suffering from conditions such as Wet Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion. Operating within the healthcare and pharmaceutical markets, Kodiak Sciences employs a business model centered on extensive clinical research and development, followed by the commercialization of its proprietary treatments. Revenue is generated through the sale of these therapeutics, which are designed to offer long-term efficacy and safety. The company’s flagship product, KSI-301, has shown promising results in Phase 1b clinical trials, demonstrating durability, efficacy, and safety over a one-year period. Kodiak Sciences aims to address significant unmet medical needs in ophthalmology, leveraging its innovative science to improve patient outcomes.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2009
- Headquarters
- Palo Alto, United States
- Listing
- IPO 2018
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
ArrowMark Partners
Perceptive Advisors
Series B and later1 investor entered at this stage
Braidwell
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
20 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kodiak Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kodiak Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.